Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids

European Respiratory Journal

Volumn 36, Issue 3, 2010, Pages 503-508

  Otsuki, M ^a   Miyatake, A ^b   Fujita, K ^c   Hamasaki, T ^a   Kasayama, S ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyatake Asthma Clinic   (Japan)

^c UNIVERSITY OF SHIGA PREFECTURE   (Japan)

Author keywords

Asthma; Atherosclerosis; Glucocorticoid receptor; Inflammation; Inhaled corticosteroid

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; THEOPHYLLINE;

ADULT; AGING; ANTIINFLAMMATORY ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; ASTHMA; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE;

ADRENAL CORTEX HORMONES; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; CAROTID ARTERY DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77956584760     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00090009     Document Type: Article

References (33)

1. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma: Summary Report 2007. J Allergy Clin Immunol 2007; 120: S94-S138.
2. Statement by the British Thoracic Society, the British Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine and the British Paediatric Respiratory Group. Guidelines on the management of asthma. Thorax 1993; 48: S1-S24.
3. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993; 148: S1-S26.
4. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006; 100: 1307-1317.
5. Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 2001; 16: 782-787. (Pubitemid 32230608)
6. Allen DB, Bielory L, Derendorf H, et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003; 112: S1-S40.
7. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
8. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 1986; 80: 925-929.
9. Varas-Lorenzo C, Rodriguez LA, Maguire A, et al. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis 2007; 192: 376-383. (Pubitemid 46745271)
10. Cronstein BN, Kimmel SC, Levin RI, et al. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89: 9991-9995.
11. Simoncini T, Maffei S, Basta G, et al. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 2000; 87: 19-25. (Pubitemid 30456930)
12. Bevilacqua MP, Nelson RM, Mannori G, et al. Endothelialleukocyte adhesion molecules in human disease. Annu Rev Med 1994; 45: 361-378. (Pubitemid 24158168)
13. Suissa S, Assimes T, Brassard P, et al. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med 2003; 115: 377-381. (Pubitemid 37311255)
14. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
15. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136: 225-244.
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197. (Pubitemid 27274286)
17. Adams N, Bestall JM, Lasserson TJ, et al. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children. Cochrane Database Syst Rev 2005; 2: CD002310.
18. Buhl R, Vinkler I, Magyar P, et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther 2006; 19: 404-412. (Pubitemid 44234118)
19. Lasserson TJ, Cates CJ, Jones AB, et al. Fluticasone versus HFAbeclomethasone dipropionate for chronic asthma in adults and children. Cochrane Database Syst Rev 2005; 4: CD005309.
20. Yamasaki Y, Kawamori R, Matsushima H, et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 1994; 43: 634-639. (Pubitemid 24138774)
21. Otsuki M, Hashimoto K, Morimoto Y, et al. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 1997; 46: 2096-2101. (Pubitemid 27512102)
22. Salonen R, Seppanen K, Rauramaa R, et al. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988; 8: 788-792. (Pubitemid 19005365)
23. Akaike H. Information Theory and an Extension of the Maximum Likelihood Principle. Budapest, Academia Kaido, 1972.
24. Moreland LW, O'Dell JR. Glucocorticoids and rheumatoid arthritis: back to the future? Arthritis Rheum 2002; 46: 2553-2563.
25. del Rincon I, O'Leary DH, Haas RW, et al. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004; 50: 3813-3822. (Pubitemid 39643928)
26. Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev 2008; 4: 116-122.
27. Spence JD. Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J Stroke 2006; 1: 216-221.
28. Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 2005; 5: 57-63.
29. Hsieh FY. Sample size tables for logistic regression. Stat Med 1989; 8: 795-802.
30. Makheja AN, Bloom S, Muesing R, et al. Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate. Atherosclerosis 1989; 76: 155-161.
31. Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-479. (Pubitemid 34546749)
32. Atsuta J, Plitt J, Bochner BS, et al. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol 1999; 20: 643-650. (Pubitemid 129495652)
33. Camargo CA Jr, Barr RG, Chen R, et al. Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest 2008; 134: 546-551.